HMGN
Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its human diagnostics products also comprise Universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and specialty assays, including Chagas, acute phase proteins, and cytokines. In addition, the company provides veterinary diagnostic products, such as equipment, reagents, supplies, accessories, and electrodes in chemistry, hematology, and electrolyte areas. It sells its products directly, as well as through distributors to various laboratories, hospitals, and blood banks. The company was founded in 1985 and is based in Columbia, Maryland.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2012 Q4 | -0.01 | $875,912 | -$54,402 |
| 2012 Q3 | -0.01 | $947,807 | $1,478 |
| 2012 Q2 | -0.02 | $1M | -$123,916 |
| 2011 Q1 | -0.02 | $1M | -$272,884 |
| 2011 Q4 | -0.02 | $1M | $47,978 |
| 2011 Q3 | -0.00 | $1M | -$347,926 |
| 2011 Q2 | -0.02 | $1M | -$128,881 |
| 2010 Q1 | -0.01 | $1M | $35,247 |